| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000023100 |
| Receipt No. | R000026626 |
| Official scientific title of the study | The Single-center Prospective Randomized Controlled Trial Evaluating Efficacy and Safety of Catheter Ablation without Periprocedual Contrast Media for Paroxysmal Atrial Fibrillation: Sophisticated Atrial Fibrillation ablation procedurE contrasT media unnecessitY (SAFETY) trial |
| Date of disclosure of the study information | 2016/09/10 |
| Last modified on | 2016/08/30 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The Single-center Prospective Randomized Controlled Trial Evaluating Efficacy and Safety of Catheter Ablation without Periprocedual Contrast Media for Paroxysmal Atrial Fibrillation: Sophisticated Atrial Fibrillation ablation procedurE contrasT media unnecessitY (SAFETY) trial | |
| Title of the study (Brief title) | SAFETY trial | |
| Region |
|
|
| Condition | ||
| Condition | Paroxysmal atrial fibrillation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to evaluate the efficacy and safety of catheter ablation without periprocedual contrast media for paroxysmal atrial fibrillation compared with conventional strategy with contrast media. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Event-free rate from atrial tachyarrhythmia after procedure |
| Key secondary outcomes | Any procedural complications
Total time required for mapping of left atrium during procedure Total procedure time Total fluoroscopy time Total radiation dose Total number of energy applications Incidence of dormant conduction Renal function after procedur |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients are randomized in a 1:1 ratio to catheter ablation for paroxysmal atrial fibrillation with or without periprocedual contrast media.
In contrast group,contrast media was used for 3D mapping left atrium in computed tomography before procedure and left atrium angiography during procedure. |
|
| Interventions/Control_2 | In group without contrast, contrast media was not used during computed tomography before procedure and during procedure. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients undergoing first catheter ablation for paroxysmal atrial fibrillation, who are 20-80 years old, able to be followed for one year in an out-patient clinic and willing to sign the consent form for participation, are eligible for the study. | |||
| Key exclusion criteria | 1) Patients with a history of allergy for contrast media
2) Patients with renal insufficiency (eGFR <=45ml/min/1.73m2 3) Left ventricular ejection fraction < 40% 4) Left atrial diameter > 50mm 5) Patients with a history of open heart surgery 6) Patients with moderate or severe valve heart disease 7) Patients who need additional ablation such as tricuspid valve isthmus ablation during procedure 8) Patients unwilling to sign the consent form for participation |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Satoshi Shizuta |
| Organization | Kyoto University Graduate School of Medicine |
| Division name | Department of Cardiology |
| Address | 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan |
| TEL | 075-751-4255 |
| shizuta@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Tetsuma Kawaji |
| Organization | Kyoto University Graduate School of Medicine, |
| Division name | Department of Cardiology |
| Address | 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507 Japan |
| TEL | 075-751-4255 |
| Homepage URL | |
| kawaji@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Kyoto University Graduate School of Medicine, |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kyoto University Graduate School of Medicine, |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026626 |